MSD to push for approval of HIV combo after Phase III success
|
Merck & Co (MSD) is looking to file for approval of
its human immunodeficiency virus (HIV) treatment after two positive
Phase III trial readouts. |
Impact of US funding cuts on HIV programmes in Angola
While stocks of antiretroviral supplies, HIV, viral load and other lab test kits are available, recent reports indicate challenges with distribution. View article...